TNF-alpha promoter polymorphism in relation to TNF-alpha production and clinical status in cystic fibrosis (Q45177872)

10 December 2017

title

TNF-alpha promoter polymorphism in relation to TNF-alpha production and clinical status in cystic fibrosis (English)

1 reference

10 December 2017

0 references

0 references

Sabina Schmitt-Grohé

1

0 references

author name string

Frank Stüber

2

1 reference

10 December 2017

Malte Book

3

1 reference

10 December 2017

Joachim Bargon

4

1 reference

10 December 2017

Thomas O Wagner

5

1 reference

10 December 2017

Christian Naujoks

6

1 reference

10 December 2017

Ralf Schubert

7

1 reference

10 December 2017

Michael J Lentze

8

1 reference

10 December 2017

Stefan Zielen

9

1 reference

10 December 2017

publication date

1 March 2006

1 reference

10 December 2017

1 reference

10 December 2017

volume

184

1 reference

10 December 2017

issue

2

1 reference

10 December 2017

page(s)

99-104

1 reference

Tumour Necrosis Factor-α, Resting Energy Expenditure and Cachexia in Cystic Fibrosis

10 December 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00408-005-2568-X

Bone density, body composition, and inflammatory status in cystic fibrosis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00408-005-2568-X

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00408-005-2568-X

Severity of cystic fibrosis in patients homozygous and heterozygous for ΔF508 mutation

21 January 2018

1 reference

12 December 2020

Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates.

1 reference

12 December 2020

End-organ dysfunction in cystic fibrosis: association with angiotensin I converting enzyme and cytokine gene polymorphisms.

1 reference

12 December 2020

The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

1 reference

12 December 2020

Pancreatic function and gene deletion F508 in cystic fibrosis

1 reference

12 December 2020

Plasma tumour necrosis factor alpha in cystic fibrosis

1 reference

12 December 2020

TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients

1 reference

12 December 2020

Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis

1 reference

12 December 2020

-308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter

1 reference

12 December 2020

Cytokine release by lipopolysaccharide-stimulated whole blood from patients with typhoid fever

1 reference

12 December 2020

Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus

1 reference

12 December 2020

The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis.

1 reference

12 December 2020

Genetic influence on cytokine production and fatal meningococcal disease

1 reference

12 December 2020

Gene polymorphism at position -308 of the tumor necrosis factor alpha promotor is not associated with disease progression in multiple sclerosis patients

1 reference

12 December 2020

Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis

1 reference

12 December 2020

A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection

1 reference

12 December 2020

Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis

1 reference

12 December 2020

The relation between genotype and phenotype in cystic fibrosis--analysis of the most common mutation (delta F508).

1 reference

12 December 2020

The tumour necrosis factor alpha -238 G --> A and -308 G --> A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of Type II diabetic patients.

1 reference

12 December 2020

Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies

1 reference

12 December 2020

Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-alpha response of granulocytes to endotoxin stimulation.

1 reference

12 December 2020

Cystic fibrosis: relationship between clinical status and F508 deletion

1 reference

12 December 2020

Polymorphisms at position -308 in the promoter region of the TNF-alpha and in the first intron of the TNF-beta genes and spontaneous and lipopolysaccharide-induced TNF-alpha release in sarcoidosis

1 reference

12 December 2020

10.1007/S00408-005-2568-X

Identifiers

DOI

1 reference

Dimensions Publication ID

10 December 2017

1015314887

0 references

1 reference